Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?

Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?

Bibliographic Details
Main Authors: Alberto Zambelli, Carlo Alberto Tondini
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/5/Suppl_3/e000836.full
id doaj-d308c45fccf04f9193ecfeaa14c8cffe
record_format Article
spelling doaj-d308c45fccf04f9193ecfeaa14c8cffe2021-04-02T17:59:49ZengElsevierESMO Open2059-70292020-11-015Suppl 310.1136/esmoopen-2020-000836Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?Alberto Zambelli0Carlo Alberto Tondini1Department of Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy Department of Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy https://esmoopen.bmj.com/content/5/Suppl_3/e000836.full
collection DOAJ
language English
format Article
sources DOAJ
author Alberto Zambelli
Carlo Alberto Tondini
spellingShingle Alberto Zambelli
Carlo Alberto Tondini
Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
ESMO Open
author_facet Alberto Zambelli
Carlo Alberto Tondini
author_sort Alberto Zambelli
title Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_short Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_full Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_fullStr Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_full_unstemmed Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_sort can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current covid-19 outbreak in italy?
publisher Elsevier
series ESMO Open
issn 2059-7029
publishDate 2020-11-01
url https://esmoopen.bmj.com/content/5/Suppl_3/e000836.full
work_keys_str_mv AT albertozambelli canmultigeneassayswidentheirclinicalusefulnessinearlybreastcancertreatmentchoiceduringthecurrentcovid19outbreakinitaly
AT carloalbertotondini canmultigeneassayswidentheirclinicalusefulnessinearlybreastcancertreatmentchoiceduringthecurrentcovid19outbreakinitaly
_version_ 1721552810015719424

Similar Items